Literature DB >> 27872992

Atrial Septal Defect Closure with Occlutech® ASD Fenestrated Device in a Child with Severe Pulmonary Hypertension.

Francisco Gonzalez-Barlatay1, Anne Fournier1, Marie-Josée Raboisson1, Nagib Dahdah2.   

Abstract

We report a 5-year-old patient with severe pulmonary hypertension and a large secundum atrial septal defect who benefited from a percutaneous closure of the defect with an Occlutech® custom-made fenestrated device. Whereas the closure is technically identical to standard atrial defect closure, the immediate and midterm beneficial results are presented.

Entities:  

Keywords:  Atrial septal defect; Fenestrated device; Partial defect closure; Pulmonary hypertension

Mesh：

Year:  2016        PMID： 27872992     DOI： 10.1007/s00246-016-1530-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  8 in total

1.  Shunt reduction with a fenestrated Amplatzer device.

Authors:  Oliver Kretschmar; Anca Sglimbea; Roberto Corti; Walter Knirsch
Journal:  Catheter Cardiovasc Interv       Date:  2010-10-01       Impact factor: 2.692

2.  Lifetime Risk of Pulmonary Hypertension for All Patients After Shunt Closure.

Authors:  Annelieke C M J van Riel; Ilja M Blok; Aeilko H Zwinderman; Elly M C J Wajon; Arthur S J M Sadee; Mirjam Bakker-de Boo; Arie P J van Dijk; Elke S Hoendermis; Robert K Riezebos; Barbara J M Mulder; Berto J Bouma
Journal:  J Am Coll Cardiol       Date:  2015-09-01       Impact factor: 24.094

3.  Atrial septal defect closure in a patient with "irreversible" pulmonary hypertensive arteriopathy.

Authors:  Markus Schwerzmann; Moiz Zafar; Peter R McLaughlin; Dean W Chamberlain; Gary Webb; John Granton
Journal:  Int J Cardiol       Date:  2005-07-01       Impact factor: 4.164

4.  Fate of a modified fenestration of atrial septal occluder device after transcatheter closure of atrial septal defects in elderly patients.

Authors:  Heike E Schneider; Christian Jux; Thomas Kriebel; Thomas Paul
Journal:  J Interv Cardiol       Date:  2011-06-01       Impact factor: 2.279

5.  Transcatheter closure of secundum ASD using Occlutech Figulla-N device in symptomatic children younger than 2 years of age.

Authors:  Rasha I Ammar; Ranya A Hegazy
Journal:  J Invasive Cardiol       Date:  2013-02       Impact factor: 2.022

6.  Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  David B Badesch; Steve H Abman; Gregory S Ahearn; Robyn J Barst; Douglas C McCrory; Gerald Simonneau; Vallerie V McLaughlin
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

7.  ASD closure under pressure.

Authors:  Suhair Omar Shebani; Gregory James Skinner; Christopher Duke
Journal:  BMJ Case Rep       Date:  2014-09-11

8.  Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension.

Authors:  Gregory J Skinner; Robert M Tulloh; Andrew J Tometzki; Ingram Schulze-Neick; Gareth J Morgan
Journal:  Cardiol Young       Date:  2012-10-23       Impact factor: 1.093
  8 in total
  5 in total

Review 1.  Hemodynamic assessment of atrial septal defects.

Authors:  Alejandro Javier Torres
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 2.  Atrial septal defect closure: indications and contra-indications.

Authors:  Alain Fraisse; Monica Latchman; Shiv-Raj Sharma; Selin Bayburt; Pascal Amedro; Giovanni di Salvo; Alban Elouen Baruteau
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 3.  The Medical Devices Special Access Program in Canada: A Scoping Study.

Authors:  Roland K Maier; Devidas Menon; Tania Stafinski
Journal:  Healthc Policy       Date:  2018-02

4.  Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.

Authors:  Palaparti Raghuram; Sreeja Pavithran; Kothandam Sivakumar
Journal:  Indian Heart J       Date:  2020-07-28

5.  Percutaneous closure of residual shunting in a patient with a fenestrated atrial septal defect occluder: A case report.

Authors:  Wang Man; Ma Xinxin; Zhang Yueli; Li Feng
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.